Income Statement Yidu Tech Inc.

Equities

2158

KYG9845C1069

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. Other stock markets 04:08:12 2026-04-16 am EDT			5-day change	1st Jan Change
5.720 ^HKD	+1.78%		+6.72%	+8.95%

Apr. 13	Yidu Tech says affiliate wins Hainan phase II infectious disease platform project	RE
Apr. 13	Yidu Tech Affiliate Wins Infectious Disease Monitoring Project in China	MT

35605800d5c3b3def9291.tFDIoi_F-xCcsbdekLkOzjHWRd3vWWbpUcChqCssPG4.-WCL52GKkXvRgYcd2fhIhmKmErOdMTaYHrTYmVxOWFbRaYr1XK63VMrm_g

Published financial data: YIDU TECH INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	867M	1.24B	805M	807M	715M
Total Revenues	867M	1.24B	805M	807M	715M
Cost of Goods Sold, Total	540M	840M	530M	468M	476M
Gross Profit	327M	397M	275M	339M	239M
Selling General & Admin Expenses, Total	499M	751M	504M	380M	286M
Provision for Bad Debts	15.58M	47.31M	61M	98.57M	77.62M
R&D Expenses	222M	369M	343M	233M	186M
Other Operating Expenses	-18.68M	-26.78M	-15.05M	-21.2M	-7.81M
Other Operating Expenses, Total	718M	1.14B	892M	691M	542M
Operating Income	-391M	-743M	-618M	-352M	-303M
Interest Expense, Total	-3.29M	-4.21M	-2.61M	-3.31M	-2.01M
Interest And Investment Income	2.37M	5.51M	78.76M	143M	159M
Net Interest Expenses	-926K	1.3M	76.15M	140M	157M
Income (Loss) On Equity Invest.	-1.84M	-207K	-4.28M	-8.47M	-1.08M
Currency Exchange Gains (Loss)	-16.59M	-6.56M	-84.61M	-4.42M	6.02M
Other Non Operating Income (Expenses)	34.4M	-3.4M	-951K	-5.52M	-893K
EBT, Excl. Unusual Items	-376M	-752M	-631M	-230M	-142M
Impairment of Goodwill	-	-4.36M	-	-	-
Gain (Loss) On Sale Of Investments	1.05M	-	8.8M	10.18M	7.08M
Gain (Loss) On Sale Of Assets	-	-	1.87M	-	-35K
Asset Writedown	-	-4.12M	-3.26M	-	-
Legal Settlements	-	-6.24M	-5.07M	-1.13M	-178K
Other Unusual Items	-3.32B	-	-	21K	-
EBT, Incl. Unusual Items	-3.69B	-767M	-629M	-221M	-135M
Income Tax Expense	1.42M	-486K	3.42M	49K	298K
Earnings From Continuing Operations	-3.69B	-766M	-632M	-221M	-135M
Net Income to Company	-3.69B	-766M	-632M	-221M	-135M
Minority Interest	-5.47M	4.04M	4.4M	26.3M	17.44M
Net Income - (IS)	-3.7B	-762M	-628M	-195M	-118M
Net Income to Common Incl Extra Items	-3.7B	-762M	-628M	-195M	-118M
Net Income to Common Excl. Extra Items	-3.7B	-762M	-628M	-195M	-118M
Per Share Items
Net EPS - Basic	-7.24	-0.8	-0.63	-0.19	-0.11
Basic EPS - Continuing Operations	-7.24	-0.8	-0.63	-0.19	-0.11
Basic Weighted Average Shares Outstanding	511M	958M	995M	1.05B	1.06B
Net EPS - Diluted	-7.24	-0.8	-0.63	-0.19	-0.11
Diluted EPS - Continuing Operations	-7.24	-0.8	-0.63	-0.19	-0.11
Diluted Weighted Average Shares Outstanding	511M	958M	995M	1.05B	1.06B
Normalized Basic EPS	-0.47	-0.49	-0.39	-0.11	-0.07
Normalized Diluted EPS	-0.47	-0.49	-0.39	-0.11	-0.07
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	-372M	-720M	-592M	-321M	-274M
EBITA	-389M	-741M	-616M	-350M	-301M
EBIT	-391M	-743M	-618M	-352M	-303M
EBITDAR	-369M	-711M	-586M	-317M	-271M
Effective Tax Rate - (Ratio)	-0.04	0.06	-0.54	-0.02	-0.22
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	1.94M	-	2.53M	-2K	34K
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	-527K	-486K	893K	51K	264K
Normalized Net Income	-240M	-466M	-390M	-118M	-71.19M
Interest on Long-Term Debt	3.29M	4.21M	2.61M	1.86M	1.07M
Supplemental Operating Expense Items
Advertising Expense	39.72M	106M	34.35M	25.22M	7.99M
Selling and Marketing Expenses	239M	414M	272M	209M	139M
General and Administrative Expenses	260M	337M	232M	171M	146M
Research And Development Expense From Footnotes	222M	369M	343M	233M	186M
Net Rental Expense, Total	3.39M	8.92M	5.97M	4.56M	3.58M
Imputed Operating Lease Interest Expense	39.17K	7.65M	3.76M	2.21M	513K
Imputed Operating Lease Depreciation	3.35M	1.27M	2.21M	2.35M	3.07M
Stock-Based Comp., COGS (Total)	7.3M	13.2M	8M	5.5M	2.9M
Stock-Based Comp., R&D Exp. (Total)	18.3M	42.2M	26.3M	14M	-
Stock-Based Comp., S&M Exp. (Total)	14.6M	27.9M	17.1M	13.5M	-
Stock-Based Comp., G&A Exp. (Total)	-	99.5M	47.6M	25.7M	9.1M
Stock-Based Comp., Other (Total)	94.46M	39K	35K	10K	-
Total Stock-Based Compensation	135M	183M	99.04M	58.71M	12M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	740M	3.41B	1.17B	1.41B	1.32B
Short Term Investments	3.88B	328M	2.35B	2.23B	1.95B
Trading Asset Securities, Total	20.94M	36.93M	230M	70.15M	17M
Total Cash And Short Term Investments	4.64B	3.77B	3.75B	3.7B	3.29B
Accounts Receivable, Total	417M	672M	598M	587M	519M
Other Receivables	1.28M	-	21.15M	1.01M	3.53M
Notes Receivable	0	0	-	-	-
Total Receivables	418M	672M	619M	588M	523M
Inventory	40.1M	9.47M	5.71M	6.44M	15.58M
Prepaid Expenses	15.64M	10.1M	54.8M	44.71M	31.13M
Restricted Cash	-	-	-	14.49M	37.57M
Other Current Assets, Total	38.58M	87.37M	79.32M	76.68M	75.13M
Total Current Assets	5.15B	4.55B	4.51B	4.43B	3.97B
Gross Property Plant And Equipment	167M	258M	238M	279M	331M
Accumulated Depreciation	-118M	-155M	-154M	-186M	-168M
Net Property Plant And Equipment	49.57M	103M	83.83M	92.94M	163M
Long-term Investments	5.22M	26.38M	269M	246M	510M
Goodwill	4.36M	0	0	0	0
Other Intangibles, Total	34.84M	35.25M	39.53M	39.12M	33.95M
Deferred Tax Assets Long-Term	752K	1.24M	345K	294K	30K
Other Long-Term Assets, Total	5.01M	5.02M	7.47M	12.13M	15.68M
Total Assets	5.25B	4.72B	4.91B	4.82B	4.69B
Liabilities
Accounts Payable, Total	85.88M	211M	160M	175M	142M
Accrued Expenses, Total	230M	270M	270M	274M	229M
Short-term Borrowings	-	-	-	80M	122M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	19.52M	26.18M	9.54M	8.79M	2M
Current Income Taxes Payable	2.19M	245K	1.54M	234K	234K
Unearned Revenue Current, Total	31.81M	43.76M	61.15M	49.83M	68.73M
Other Current Liabilities	45.6M	61.16M	168M	66.17M	72.73M
Total Current Liabilities	415M	612M	671M	654M	636M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	6.91M	25.99M	4.59M	6.42M	5.55M
Unearned Revenue Non Current	76.21M	77.77M	79.76M	71.3M	69.74M
Total Liabilities	498M	715M	755M	732M	711M
Common Stock, Total	116K	124K	131K	135K	136K
Additional Paid In Capital	11.26B	11.37B	11.84B	12B	12.13B
Retained Earnings	-7.48B	-8.24B	-8.87B	-9.06B	-9.18B
Treasury Stock	-1K	-1K	-1K	-4.52M	-13.71M
Comprehensive Income and Other	949M	859M	1.11B	1.09B	984M
Total Common Equity	4.73B	3.99B	4.08B	4.02B	3.92B
Minority Interest	22.62M	17.67M	73.79M	69.12M	56.43M
Total Equity	4.75B	4.01B	4.16B	4.09B	3.98B
Total Liabilities And Equity	5.25B	4.72B	4.91B	4.82B	4.69B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	925M	987M	1.04B	1.05B	1.06B
ECS Total Common Shares Outstanding	925M	987M	1.04B	1.05B	1.06B
Book Value / Share	5.11	4.04	3.94	3.82	3.7
Tangible Book Value	4.69B	3.95B	4.04B	3.98B	3.89B
Tangible Book Value Per Share	5.07	4.01	3.9	3.78	3.67
Total Debt	26.43M	52.16M	14.13M	95.2M	130M
Net Debt	-4.61B	-3.72B	-3.74B	-3.61B	-3.16B
Debt Equivalent Oper. Leases	27.09M	71.35M	47.75M	36.52M	28.63M
Minority Interest, Total (Incl. Fin. Div)	22.62M	17.67M	73.79M	69.12M	56.43M
Equity Method Investments, Total	5.22M	9.92M	5.28M	32.72M	39.43M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Finished Goods, Total	31.76M	8.29M	6.31M	7.75M	14.21M
Buildings, Total	-	-	-	-	39.64M
Machinery, Total	87.41M	108M	120M	150M	150M
Full Time Employees	1.2K	1.4K	1.02K	902	823
Accumulated Allowance for Doubtful Accounts (Supple)	43.85M	85.73M	107M	170M	205M
Order Backlog	-	-	916M	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-3.7B	-762M	-628M	-195M	-118M
Depreciation & Amortization - CF	32.89M	41.54M	39.1M	39.17M	34.43M
Amortization of Goodwill and Intangible Assets - (CF)	1.81M	1.81M	1.67M	1.61M	1.58M
Depreciation & Amortization, Total	34.7M	43.36M	40.77M	40.78M	36.01M
Amortization of Deferred Charges, Total - (CF)	1.72M	5.49M	5.58M	6.34M	7.28M
(Gain) Loss From Sale Of Asset	479K	1M	499K	-21K	35K
(Gain) Loss on Sale of Investments - (CF)	16.53M	41.62M	63.96M	94.72M	71.53M
Asset Writedown & Restructuring Costs	-	8.48M	3.26M	-	-
(Income) Loss On Equity Investments - (CF)	1.84M	207K	4.28M	8.47M	1.08M
Stock-Based Compensation (CF)	135M	183M	99.04M	58.71M	6.7M
Other Operating Activities, Total	3.26B	2.09M	11.68M	-154M	-190M
Change In Accounts Receivable	-135M	-305M	22.25M	-87.56M	-9.42M
Change In Inventories	35.74M	23.48M	1.98M	-1.44M	-8.5M
Change In Accounts Payable	7.17M	135M	35.8M	-93.87M	-36.36M
Change in Unearned Revenues	-48.06M	13.51M	19.38M	-19.79M	17.35M
Change In Income Taxes	-	-	1.29M	-1.3M	-
Change in Other Net Operating Assets	61.76M	-4.4M	-38.81M	18.02M	-26.31M
Cash from Operations	-332M	-615M	-357M	-326M	-249M
Capital Expenditure	-14.29M	-57.47M	-17.59M	-39.23M	-102M
Sale of Property, Plant, and Equipment	-	-	-	165K	40K
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	377K	-
Sale (Purchase) of Intangible assets	-4.76M	-11.33M	-3.59M	-1.58M	-159K
Investment in Marketable and Equity Securities, Total	-3.86B	3.45B	-2.37B	381M	172M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	483K	1.82M	49.61M	126M	46.61M
Cash from Investing	-3.87B	3.39B	-2.34B	467M	117M
Short Term Debt Issued, Total	-	-	-	78.55M	121M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	78.55M	121M
Short Term Debt Repaid, Total	-	-	-	-	-80M
Long-Term Debt Repaid, Total	-14.41M	-15.84M	-20.5M	-4.42M	-10.06M
Total Debt Repaid	-14.41M	-15.84M	-20.5M	-4.42M	-90.06M
Issuance of Common Stock	3.81B	2.17M	5.46M	6.28M	9.35M
Repurchase of Common Stock	-5.24M	-4.61M	-	-	-20.3M
Issuance of Preferred Stock	282M	-	-	-	-
Other Financing Activities, Total	186M	-16.95M	376M	1.8M	-
Cash from Financing	4.26B	-35.23M	361M	82.21M	20.04M
Foreign Exchange Rate Adjustments	-32.71M	-67.93M	100M	12.1M	20.84M
Net Change in Cash	20.12M	2.67B	-2.24B	235M	-91.22M
Supplemental Items
Cash Interest Paid	3.29M	4.21M	2.61M	1.86M	-
Cash Income Tax Paid (Refund)	-	1.94M	1.22M	1.3M	34K
Levered Free Cash Flow	-222M	-368M	-168M	-224M	-242M
Unlevered Free Cash Flow	-220M	-366M	-166M	-222M	-241M
Change In Net Working Capital	128M	64.04M	-95.82M	67.09M	5.04M
Net Debt Issued / Repaid	-14.41M	-15.84M	-20.5M	74.12M	31M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	-7.46	-9.32	-8.01	-4.52	-3.98
Return on Total Capital	-8.76	-10.51	-9.38	-5.26	-4.56
Return On Equity %	-720.29	-17.5	-15.49	-5.36	-3.35
Return on Common Equity	-737.06	-17.49	-15.56	-4.81	-2.97
Margin Analysis
Gross Profit Margin %	37.75	32.08	34.11	41.96	33.45
SG&A Margin	57.6	60.7	62.59	47.11	39.94
EBITDA Margin %	-42.9	-58.19	-73.55	-39.83	-38.38
EBITA Margin %	-44.87	-59.93	-76.54	-43.39	-42.11
EBIT Margin %	-45.08	-60.08	-76.75	-43.59	-42.33
Income From Continuing Operations Margin %	-426.14	-61.94	-78.58	-27.41	-18.91
Net Income Margin %	-426.77	-61.62	-78.04	-24.15	-16.47
Net Avail. For Common Margin %	-426.77	-61.62	-78.04	-24.15	-16.47
Normalized Net Income Margin	-27.72	-37.67	-48.48	-14.57	-9.96
Levered Free Cash Flow Margin	-25.65	-29.77	-20.83	-27.76	-33.87
Unlevered Free Cash Flow Margin	-25.41	-29.56	-20.63	-27.5	-33.69
Asset Turnover
Asset Turnover	0.26	0.25	0.17	0.17	0.15
Fixed Assets Turnover	14.67	16.25	8.63	9.13	5.6
Receivables Turnover (Average Receivables)	2.43	2.27	1.27	1.36	1.29
Inventory Turnover (Average Inventory)	8.5	33.9	69.86	77.12	43.21
Short Term Liquidity
Current Ratio	12.42	7.44	6.72	6.77	6.24
Quick Ratio	12.19	7.27	6.51	6.56	5.99
Operating Cash Flow to Current Liabilities	-0.8	-1.01	-0.53	-0.5	-0.39
Days Sales Outstanding (Average Receivables)	150.1	160.65	288.07	268.78	282.35
Days Outstanding Inventory (Average Inventory)	42.93	10.77	5.22	4.75	8.45
Average Days Payable Outstanding	74.42	66.83	128.63	130.84	119.21
Cash Conversion Cycle (Average Days)	118.61	104.59	164.67	142.69	171.59
Long Term Solvency
Total Debt/Equity	0.56	1.3	0.34	2.33	3.26
Total Debt / Total Capital	0.55	1.28	0.34	2.27	3.15
LT Debt/Equity	0.15	0.65	0.11	0.16	0.14
Long-Term Debt / Total Capital	0.14	0.64	0.11	0.15	0.14
Total Liabilities / Total Assets	9.48	15.15	15.38	15.18	15.17
EBIT / Interest Expense	-118.7	-176.42	-236.54	-106.26	-150.42
EBITDA / Interest Expense	-108.16	-166.13	-220.92	-93.95	-132.53
(EBITDA - Capex) / Interest Expense	-112.5	-179.77	-227.66	-105.8	-183.13
Total Debt / EBITDA	-0.07	-0.07	-0.02	-0.31	-0.49
Net Debt / EBITDA	12.95	5.32	6.48	11.6	11.83
Total Debt / (EBITDA - Capex)	-0.07	-0.07	-0.02	-0.27	-0.35
Net Debt / (EBITDA - Capex)	12.45	4.91	6.29	10.3	8.56
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	55.36	42.69	-34.96	0.3	-11.41
Gross Profit, 1 Yr. Growth %	123.38	21.25	-30.84	23.38	-29.38
EBITDA, 1 Yr. Growth %	-36.03	93.53	-19.63	-44.57	-14.63
EBITA, 1 Yr. Growth %	-35.24	90.58	-18.74	-42.01	-14.03
EBIT, 1 Yr. Growth %	-35.11	90.16	-18.72	-41.91	-13.98
Earnings From Cont. Operations, 1 Yr. Growth %	144.46	-79.26	-17.49	-65.01	-38.88
Net Income, 1 Yr. Growth %	145.07	-79.4	-17.62	-68.96	-39.58
Normalized Net Income, 1 Yr. Growth %	-34.42	93.89	-18.1	-69.27	-39.48
Diluted EPS Before Extra, 1 Yr. Growth %	93.79	-89.01	-20.72	-70.62	-39.85
Accounts Receivable, 1 Yr. Growth %	40.89	61.12	-10.98	-1.84	-11.61
Inventory, 1 Yr. Growth %	-53.83	-76.38	-39.75	12.86	141.92
Net Property, Plant and Equip., 1 Yr. Growth %	-27.77	107.22	-18.39	10.86	74.87
Total Assets, 1 Yr. Growth %	302.84	-10.04	4	-1.78	-2.8
Tangible Book Value, 1 Yr. Growth %	-224.59	-15.69	2.23	-1.46	-2.42
Common Equity, 1 Yr. Growth %	-226.95	-15.64	2.32	-1.46	-2.52
Cash From Operations, 1 Yr. Growth %	-8.01	85.32	-41.92	-8.58	-23.77
Capital Expenditures, 1 Yr. Growth %	-50.41	302.18	-69.4	123.07	159.49
Levered Free Cash Flow, 1 Yr. Growth %	50.16	57.21	-55.74	39.9	8.07
Unlevered Free Cash Flow, 1 Yr. Growth %	51.46	57.47	-55.86	40.03	8.51
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	191.54	48.89	-3.66	-19.23	-5.74
Gross Profit, 2 Yr. CAGR %	656.95	64.58	-8.43	-7.63	-6.66
EBITDA, 2 Yr. CAGR %	-5.94	11.27	26.14	-33.93	-31.21
EBITA, 2 Yr. CAGR %	-5.94	11.1	25.82	-32.03	-29.4
EBIT, 2 Yr. CAGR %	-5.77	11.08	25.7	-31.95	-29.31
Earnings From Cont. Operations, 2 Yr. CAGR %	98.93	-28.79	-58.63	-46.27	-53.76
Net Income, 2 Yr. CAGR %	99.09	-28.94	-58.8	-49.43	-56.69
Normalized Net Income, 2 Yr. CAGR %	-14.62	12.76	27.41	-50.31	-56.87
Diluted EPS Before Extra, 2 Yr. CAGR %	82.49	-53.86	-70.49	-51.74	-57.96
Accounts Receivable, 2 Yr. CAGR %	142.82	50.66	19.76	-6.52	-6.86
Inventory, 2 Yr. CAGR %	16.34	-66.98	-62.28	-17.54	65.24
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.63	22.34	30.04	-4.88	39.24
Total Assets, 2 Yr. CAGR %	161.69	90.37	-3.28	1.07	-2.29
Tangible Book Value, 2 Yr. CAGR %	42.48	2.49	-7.16	0.37	-1.94
Common Equity, 2 Yr. CAGR %	44.09	3.49	-7.09	0.41	-1.99
Cash From Operations, 2 Yr. CAGR %	-5.67	30.57	3.75	-27.13	-16.52
Capital Expenditures, 2 Yr. CAGR %	-4.8	41.23	10.94	-17.37	140.59
Levered Free Cash Flow, 2 Yr. CAGR %	-8.44	57.7	-15.42	-23.08	22.96
Unlevered Free Cash Flow, 2 Yr. CAGR %	-8.53	58.55	-15.46	-23.17	23.27
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	236.64	129.75	12.97	-2.36	-16.71
Gross Profit, 3 Yr. CAGR %	605.04	311.09	23.27	1.14	-15.53
EBITDA, 3 Yr. CAGR %	16.9	19.63	0.59	-4.75	-28.04
EBITA, 3 Yr. CAGR %	16.34	19.02	0.84	-3.44	-26.49
EBIT, 3 Yr. CAGR %	16.52	19.08	0.84	-3.45	-26.42
Earnings From Cont. Operations, 3 Yr. CAGR %	55.73	-6.37	-25.21	-60.88	-43.91
Net Income, 3 Yr. CAGR %	55.8	-6.53	-25.36	-62.51	-46.34
Normalized Net Income, 3 Yr. CAGR %	6.07	12.23	2.11	-21.2	-46.93
Diluted EPS Before Extra, 3 Yr. CAGR %	51.78	-28.48	-44.74	-70.53	-48.06
Accounts Receivable, 3 Yr. CAGR %	182.83	111.79	26.43	12.08	-8.25
Inventory, 3 Yr. CAGR %	-	-31.62	-59.65	-45.64	18.05
Net Property, Plant and Equip., 3 Yr. CAGR %	-5.87	26.95	6.9	23.31	16.52
Total Assets, 3 Yr. CAGR %	100.35	83.32	55.62	-2.78	-0.24
Tangible Book Value, 3 Yr. CAGR %	55.58	19.62	2.41	-5.3	-0.57
Common Equity, 3 Yr. CAGR %	56.02	20.54	3.1	-5.25	-0.58
Cash From Operations, 3 Yr. CAGR %	25.52	18.15	-0.33	-0.54	-26.03
Capital Expenditures, 3 Yr. CAGR %	-10.84	53.9	-15.17	40.03	21
Levered Free Cash Flow, 3 Yr. CAGR %	-	11.56	4.21	-1.48	-13.85
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	11.56	4.49	-1.49	-13.8
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	104.09	51.23	5.08
Gross Profit, 5 Yr. CAGR %	-	-	211.63	126.25	10.3
EBITDA, 5 Yr. CAGR %	-	-	20.51	-5.23	-13.94
EBITA, 5 Yr. CAGR %	-	-	20.04	-4.45	-12.9
EBIT, 5 Yr. CAGR %	-	-	20.11	-4.38	-12.86
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-8.36	-25.02	-38.29
Net Income, 5 Yr. CAGR %	-	-	-8.49	-26.89	-39.96
Normalized Net Income, 5 Yr. CAGR %	-	-	14.14	-18.63	-27.95
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-21.16	-38.89	-50.46
Accounts Receivable, 5 Yr. CAGR %	-	-	100.56	52.69	11.88
Inventory, 5 Yr. CAGR %	-	-	-	-26.3	-29.08
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	7.12	13.11	18.82
Total Assets, 5 Yr. CAGR %	-	-	49.72	44.47	29.19
Tangible Book Value, 5 Yr. CAGR %	-	-	26.55	11.51	0.64
Common Equity, 5 Yr. CAGR %	-	-	26.8	12.04	1.03
Cash From Operations, 5 Yr. CAGR %	-	-	16.31	-2.62	-7.15
Capital Expenditures, 5 Yr. CAGR %	-	-	-2.69	20	28.72
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-3.32	10.33
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-3.36	10.61